Certified Lactation Specialist Adverse Event Reporting 2 — Questions and Answers
Question 1: A lactation consultant documents that an infant developed a rash after the mother applied a lanolin-based nipple cream. Which reporting pathway is MOST appropriate?
- File a MedWatch report with the FDA (Correct answer)
- Notify the state health department only
- Document in the chart and take no further action
- Contact the infant's pediatrician and close the case
Correct answer: File a MedWatch report with the FDA
Adverse reactions to topical products used during breastfeeding should be reported to the FDA via MedWatch (Form 3500) as they involve a cosmetic or drug product.
Question 2: Under FDA regulations, a breast pump sold as a Class II medical device that causes nipple tissue injury should be reported through which system?
- MedWatch voluntary reporting
- MAUDE (Manufacturer and User Facility Device Experience) (Correct answer)
- VAERS (Vaccine Adverse Event Reporting System)
- NPDB (National Practitioner Data Bank)
Correct answer: MAUDE (Manufacturer and User Facility Device Experience)
Medical device adverse events, including injuries caused by breast pumps, are reported to the FDA's MAUDE database.
Question 3: A mother reports that her prescription domperidone (obtained abroad) caused a cardiac arrhythmia. As the lactation consultant, your FIRST action should be:
- Advise discontinuing domperidone and refer her to her prescribing provider immediately (Correct answer)
- File a MedWatch report before speaking with the mother
- Recommend switching to metoclopramide without involving a physician
- Document the symptom and monitor at the next visit
Correct answer: Advise discontinuing domperidone and refer her to her prescribing provider immediately
Patient safety is the immediate priority; the mother must be referred urgently to her provider, after which the adverse event should be documented and reported.
Question 4: Which of the following is the CORRECT definition of a 'serious adverse event' as defined by the FDA?
- Any event requiring one extra clinic visit
- An event resulting in death, hospitalization, disability, or requiring medical intervention (Correct answer)
- Any unexpected side effect documented by the patient
- An event that causes mild but persistent discomfort
Correct answer: An event resulting in death, hospitalization, disability, or requiring medical intervention
The FDA defines a serious adverse event as one resulting in death, life-threatening situation, hospitalization, disability, congenital anomaly, or requiring medical or surgical intervention.
Question 5: A hospital-employed lactation consultant discovers that a donated human milk batch was contaminated. Which reporting obligation applies FIRST?
- Report to the Joint Commission only
- Notify the human milk bank, hospital infection control, and the FDA if a regulated product is involved (Correct answer)
- Inform only the NICU medical director
- File a complaint with the state WIC office
Correct answer: Notify the human milk bank, hospital infection control, and the FDA if a regulated product is involved
Contaminated donor human milk is a patient safety issue requiring immediate notification of the milk bank, hospital infection control, and potentially the FDA if it qualifies as a regulated product.
Question 6: A lactation consultant working in an outpatient setting is NOT a mandatory reporter to MedWatch. This means:
- They are prohibited from filing MedWatch reports
- Reporting is voluntary but strongly encouraged for consumer safety (Correct answer)
- They must wait for a physician to file the report on their behalf
- Reporting is required only if the patient requests it
Correct answer: Reporting is voluntary but strongly encouraged for consumer safety
Healthcare professionals outside of mandatory reporter categories (e.g., manufacturers, distributors) may file MedWatch reports voluntarily, and doing so benefits public safety surveillance.
Question 7: When completing a MedWatch Form 3500, which piece of information is ESSENTIAL for the FDA to initiate a product safety evaluation?
- The patient's insurance provider
- A clear description of the adverse event and the suspect product (Correct answer)
- The lactation consultant's license number
- The product's retail price
Correct answer: A clear description of the adverse event and the suspect product
The FDA requires a detailed description of the adverse event and identification of the suspect product to evaluate causality and trigger a safety investigation.
Certified Lactation Specialist Adverse Event Reporting 2
A lactation consultant documents that an infant developed a rash after the mother applied a lanolin-based nipple cream.
Which reporting pathway is MOST appropriate?